Relationship Between ATP Production and Genotypes in Parkinsonism with Indication of their Deletion

Abstract

The second most common age-related neurodegenerative condition affecting the central nervous system is Parkinson's disease. Lewy bodies and significant dopaminergic neuron degeneration in the substantia nigra pars compacta are hallmarks of Parkinson's Disease (PD) neuropathology. This results in a severe striatal dopamine deficiency, which impairs motor functions. Among the clinical motor characteristics of Parkinson's Disease (PD) are bradykinesia, resting tremors, slowness of movement, muscle rigidity, and postural instability.
Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal calf serum and 5% (v/v) Pen Strep Penicillin-Streptomycin (50 pg/ml) was used to cultivate mouse embryonic fibroblasts from wild-type, CHOP-knockout, and HtrA2 KO mice. The cells were then kept in a humidified incubator at 37°C with 5% CO2.
Treatment with 6-OHDA in combination with ADEP4 or ACP5 has demonstrated that these medications may have a protective impact on CHOP-KO ATP generation. A combined HtrA2-KO/CHOP-KO model was used to examine combinations of positive and negative transcriptional feedback regulation.
Transcriptional mitochondrial quality control is eliminated when mitochondrial stress signaling is compromised. ADEP4 and ACP5, which have been demonstrated to induce mitochondrial stress signaling, were administered to mouse embryonic fibroblasts derived from wild-type, CHOP-knockout, and HtrA2-KO mice in order to ascertain the role of HtrA2 and CHOP in the transcriptional activation of the mitochondrial stress response. The current study concludes that in Parkinson's disease, HtrA2 and CHOP contribute to the transmission of stress signaling and the subsequent activation of mitochondrial quality control.